Overview

In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted)

Status:
COMPLETED
Trial end date:
2024-12-27
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the effect of food on the rate and extent of absorption and the overall bioavailability of a single dose of CTx-1301 50 mg trimodal tablets in healthy adult volunteers.
Phase:
PHASE1
Details
Lead Sponsor:
Cingulate Therapeutics
Treatments:
Dexmethylphenidate Hydrochloride